GKM Gesellschaft für Therapieforschung mbH
Rupert Lang is currently the Chief Executive Officer at GKM Gesellschaft fuer Therapieforschung mbH. Prior to that, Rupert held various titles including Corporate Operations Manager, Senior Project Manager, and Gruppenleiter. Rupert previously worked at Medpharmtec as a Project Manager. Rupert Lang obtained a Diplom in Wirtschaftschemie from Ulm University and a Vordiplom in Chemie from Ludwig-Maximilians-Universität München. Rupert completed their Abitur at Gymnasium Grafing.
This person is not in any teams
GKM Gesellschaft für Therapieforschung mbH
GKM (Gesellschaft für Therapieforschung mbH) is an independent, family-owned full-service contract research organization (CRO). We provide a comprehensive portfolio for the pharmaceutical industry, manufacturers of medical devices and academia. Headquartered in Munich, Germany, GKM has completed 1000+ clinical research projects. We are experts in planning and managing national and international clinical trials as well as non-interventional studies and early benefit assessment (AMNOG). GKM employs 100+ in-house professionals and 90+ freelance clinical research associates (CRAs) throughout the DACH region. Furthermore, we benefit from a strong and trustful CRO network to address research requests all over the world. More information about us and data privacy: https://www.gkm-therapieforschung.de/en/privacy-policy/